Mouse monoclonal antibodies were raised against plague disease biomarkers: the bacterial capsular protein fraction 1 (F1) and the low-calcium response-LcrV virulence factor (Vag). A novel tandem assay, employing BioLayer Interferometry (BLI), enabled the isolation of antibodies against four different epitopes on Vag. The tandem assay was carried out with hybridoma supernatants, circumventing the need for antibody purification. The BioLayer assay was further adopted for characterization of epitope-repetitive antigens, enabling the discovery of two unique epitopes on F1. The selected antibodies were purified and applied as "oligo-clonal" reagents for the immuno-detection of both biomarkers. The developed Homogenous Time Resolved Fluorescence (HTRF) tests were short (10 min) and simple (no washing steps), allowing for detection of 10 ng/mL F1 and 2.5 ng/mL Vag. The tests were successfully applied for detection of disease biomarkers produced by various strains during growth in blood culture vials.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001648PMC
http://dx.doi.org/10.3390/pathogens10030285DOI Listing

Publication Analysis

Top Keywords

disease biomarkers
8
tandem assay
8
epitope binning
4
binning novel
4
novel monoclonal
4
monoclonal anti
4
anti anti
4
anti lcrv
4
antibodies
4
lcrv antibodies
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!